Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 5/20 | 0.48 |
| ▸ | ACE | P12821 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ECE1 | P42892 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TACR1 | P25103 | 2/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13165228 | 1.00 | SLC1A1 (0.54) | SLC1A1MMEACEALDH1A1HPGD | |
| SCHEMBL17426 | 0.87 | SLC1A1 (0.50) | SLC1A1HTTSMN1; SMN2TACR1 | |
| SCHEMBL9990986 | 0.87 | SLC1A1 (0.50) | SLC1A1HTTSMN1; SMN2TACR1 | |
| SCHEMBL1576805 | 0.87 | SLC1A1 (0.55) | SLC1A1KMT2AHTTSMN1; SMN2TACR1 | |
| SCHEMBL3586820 | 0.84 | SLC1A1 (0.52) | SLC1A1HTTSMN1; SMN2TACR1LTA4H | |
| Trifluoroacetic Acid SCHEMBL3584694 | 0.83 | F2 (0.47) | SLC1A1TACR1 | |
| Trifluoroacetic Acid SCHEMBL25141 | 0.82 | SLC1A1 (0.45) | SLC1A1 | |
| SCHEMBL27232206 | 0.82 | SLC1A1 (0.56) | SLC1A1MMEHTTSMN1; SMN2TACR1 | |
| SCHEMBL27228895 | 0.82 | SLC1A1 (0.56) | SLC1A1MMEHTTSMN1; SMN2TACR1 | |
| SCHEMBL3585658 | 0.81 | SLC1A1 (0.49) | SLC1A1MEN1KMT2AHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070048752-A1 | Mass tags for quantitative analyses | APPLERA CORPORATION (US) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070048752-A1 | Mass tags for quantitative analyses | SRMS, PTMS, TMT1A | SLC1A1 2386/4885MME 200/4885ACE 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.